Results 61 to 70 of about 2,013,058 (186)

Prospective study of exclusive strontium-/yttrium-90 beta-irradiation of primary and recurrent pterygia with no prior surgical excision. Clinical outcome of long-term follow-up [PDF]

, 2009
PURPOSE: To evaluate the consecutive treatment results regarding pterygium recurrence and the efficacy of exclusive strontium-/yttrium-90 beta-irradiation for primary and recurrent pterygia and to analyze the functional outcome.
Aebersold, Daniel M., Greiner, Richard H., Pajic-Eggspuehler, Brigitte, Aebersold, Daniel M, Vastardis, Iraklis, Pajic, Bojan, Greiner, Richard H   +6 more
core   +2 more sources

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases

Case Reports in Oncology, 2012
Because stage 4 lung cancer is associated with dismal 5-year survival rates, new treatment approaches targeting extrapulmonary disease are necessary. Yttrium-90 microsphere radioembolization is an emerging treatment for metastatic hepatic malignancies ...
Ron C. Gaba, Janesh Lakhoo
doaj   +1 more source

Nanomedicine applications in lymphoma: Advancing precision diagnostics, targeted therapeutics, and prospective developments

VIEW, EarlyView.
Lymphoma is a group of blood cancers that can appear in lymph nodes, blood, bone marrow, spleen, liver, or the central nervous system, which makes drug delivery and disease monitoring difficult. This review summarizes how nanomedicine technologies may improve targeted treatment and imaging, while carefully separating approved or guideline‐supported ...
Mohd Ahmar Rauf, Yara Mashal, Afeefa Rao, Nasar Ata, Arun K. Iyer, Farhan Shah   +5 more
wiley   +1 more source

Durvalumab-Induced Immune Thrombocytopenia in Patients with Advanced Cholangiocarcinoma Undergoing Yttrium-90 Radioembolization

Case Reports in Oncology
Introduction: Immune thrombocytopenia (ITP) secondary to durvalumab, a programmed cell death ligand 1 inhibitor, is a rare but clinically significant immune-related adverse event.
Maaz Khan Afghan, Areeb Lutfi, Fatima Qadri, Sahrish Khan, Sana Javaid, Brian Michael Currie, Juan Pablo Rocca, Benjamin Samstein, Erika Hissong, Pashtoon Murtaza Kasi   +9 more
doaj   +1 more source

Gallium Chloride Oxide: Structure Validation of a Direct Wide Bandgap Semiconductor

Zeitschrift für anorganische und allgemeine Chemie, EarlyView.
GaClO confirmed as an independent structure type, featuring a layer‐like structure and unoccupied flat bands right above the Fermi level. Gallium chloride oxide (GaClO) was synthesised, and its crystal structure was validated using powder X‐ray diffraction, UV/VIS, NMR, and quantum chemical calculations at the level of density functional theory under ...
Sven Völkel, Lukas P. Rüthing, Hector Javier Cortes Sanchez, Jörn Schmedt auf der Günne   +3 more
wiley   +1 more source

Ion-Imprinted Polymer Concept for Selective Extraction of 90Y and 152Eu for Medical Applications and Nuclear Power Plant Monitoring

CHIMIA, 2006
The metal ion imprinted concept has been used to imprint dipicolinic derivative coordination cages in styrene-based polymeric material. This resin displays very high selectivity for yttrium and lanthanides.
Pascal Froidevaux, Steffen Happel, Anne-Sophie Chauvin   +2 more
doaj   +1 more source

Interventional oncology in children: Where are we now?

Journal of Medical Imaging and Radiation Oncology, EarlyView.
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel, Fernando Gómez Muñoz   +1 more
wiley   +1 more source

Update on yttrium-90-based radio-embolization for treatment of hepatocellular carcinoma

, 2012
BACKGROUND: Catheter-based intra-arterial therapies provided effective tumour control for unresectable hepatocellular carcinoma without distant metastasis. There was a renewed interest in the advancement of yttrium-90 radio-embolization.
Tsang, SHY, Poon, RTP, Cheung, TT, Kan, RWM   +3 more
core   +1 more source

Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis. [PDF]

, 2015
Radioembolization with yttrium-90 microspheres offers an alternative treatment option for patients with unresectable intrahepatic cholangiocarcinoma (ICC).
Gill, R.S., Axford, S.J., Al-Adra, D.P., Shi, X., Liau, S.-S., Kneteman, N.   +5 more
core   +2 more sources

Prospective randomised double‐blind trial: holmium laser lithotripsy with vs without Moses™ 2.0

BJU International, EarlyView.
Objective To assess the effect of Moses™ 2.0 (Lumenis Be Ltd., Yokneam Illit, Israel; Boston Scientific, Marlborough, MA, USA) for lithotripsy of renal stones of 8–20 mm in diameter on operative time, surgeon workload, and retropulsion. Subjects/Patients and Methods In our multicentre, randomised, double‐blind clinical trial, patients were randomised 1:
Kimberly A. Maciolek, Naren Nimmagadda, Aaron X. Lee, Amy M. Reed, Ryan S. Hsi, Tatsuki Koyama, Connor M. Forbes, Matthew S. Lee, Cyrus Chehroudi, Ezra J. Margolin, Ben H. Chew, Seth K. Bechis, Mitchell R. Humphreys, Michael E. Lipkin, Manoj Monga, Ojas Shah, Karen L. Stern, Roger L. Sur, Sri Sivalingam, Nicole L. Miller   +19 more
wiley   +1 more source